B3GLCT Gene

Name beta 3-glucosyltransferase
Description The protein encoded by this gene is a beta-1,3-glucosyltransferase that transfers glucose to O-linked fucosylglycans on thrombospondin type-1 repeats (TSRs) of several proteins. The encoded protein is a type II membrane protein. Defects in this gene are a cause of Peters-plus syndrome (PPS).[provided by RefSeq, Mar 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n B3GLCT, also known as β1,3‐glucosyltransferase (previously referred to as B3GALTL), is an enzyme that plays a critical role in a specialized glycosylation pathway. In the endoplasmic reticulum, protein O‐fucosylation of properly folded thrombospondin type 1 repeats (TSRs) is initiated by POFUT2; B3GLCT then catalyzes the subsequent addition of glucose to form a conserved disaccharide (glucose–β1,3–fucose) on these domains."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " This glucose extension is important for stabilizing the TSR fold, promoting proper folding, and facilitating efficient exit from the ER for a subset of extracellular proteins that are critical in matrix assembly and signaling. \n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Loss‐of‐function mutations in B3GLCT disrupt this glycosylation process and are causative for Peters plus syndrome, an autosomal recessive congenital disorder characterized by anterior segment dysgenesis, short stature, hand anomalies, and various systemic developmental defects."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "4", "end_ref": "8"}]}, {"type": "t", "text": " Functional analyses have shown that aberrant splicing or truncating mutations in B3GLCT lead to defective disaccharide formation, which in turn compromises protein quality control within the secretory pathway. Although studies in retinal pigment epithelium cells suggest that the secretion of some TSR‐containing proteins may be variably affected by loss of B3GLCT activity"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": ", the overall evidence indicates that B3GLCT‐mediated glycosylation is pivotal for ensuring proper extracellular matrix assembly and normal developmental signaling. \n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Deepika Vasudevan, Hideyuki Takeuchi, Sumreet Singh Johar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cub.2014.11.049"}], "href": "https://doi.org/10.1016/j.cub.2014.11.049"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25544610"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25544610"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ao Zhang, Aarya Venkat, Rahil Taujale, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peters plus syndrome mutations affect the function and stability of human β1,3-glucosyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jbc.2021.100843"}], "href": "https://doi.org/10.1016/j.jbc.2021.100843"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34058199"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34058199"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Susette Lauwen, Melissa Baerenfaenger, Sanne Ruigrok, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of the AMD-associated B3GLCT gene affects glycosylation of TSP1 without impairing secretion in retinal pigment epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Eye Res (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.exer.2021.108798"}], "href": "https://doi.org/10.1016/j.exer.2021.108798"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34695439"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34695439"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Saskia A J Lesnik Oberstein, Marjolein Kriek, Stefan J White, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peters Plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/507567"}], "href": "https://doi.org/10.1086/507567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16909395"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16909395"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Daniel Hess, Jeremy J Keusch, Saskia A Lesnik Oberstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicron-glycosylation of thrombospondin type 1 repeats."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M710251200"}], "href": "https://doi.org/10.1074/jbc.M710251200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18199743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18199743"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "E Weh, L M Reis, R C Tyler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cge.12241"}], "href": "https://doi.org/10.1111/cge.12241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23889335"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23889335"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Olfa Siala, Neila Belguith, Hassen Kammoun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Two Tunisian patients with Peters plus syndrome harbouring a novel splice site mutation in the B3GALTL gene that modulates the mRNA secondary structure."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2012.06.052"}], "href": "https://doi.org/10.1016/j.gene.2012.06.052"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22759511"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22759511"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Afif Ben Mahmoud, Olfa Siala, Riadh Ben Mansour, et al. "}, {"type": "b", "children": [{"type": "t", "text": "First functional analysis of a novel splicing mutation in the B3GALTL gene by an ex vivo approach in Tunisian patients with typical Peters plus syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2013.07.058"}], "href": "https://doi.org/10.1016/j.gene.2013.07.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23954224"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23954224"}]}]}]}
NCBI Gene ID 145173
API
Download Associations
Predicted Functions View B3GLCT's ARCHS4 Predicted Functions.
Co-expressed Genes View B3GLCT's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View B3GLCT's ARCHS4 Predicted Functions.

Functional Associations

B3GLCT has 1,433 functional associations with biological entities spanning 6 categories (disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 37 datasets.

Click the + buttons to view associations for B3GLCT from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of B3GLCT gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
CCLE Cell Line Proteomics Cell lines associated with B3GLCT protein from the CCLE Cell Line Proteomics dataset.
CellMarker Gene-Cell Type Associations cell types associated with B3GLCT gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of B3GLCT gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
ClinVar Gene-Phenotype Associations 2025 phenotypes associated with B3GLCT gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing B3GLCT protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with B3GLCT protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of B3GLCT protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by B3GLCT gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving B3GLCT gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Experimental Gene-Disease Association Evidence Scores 2025 diseases associated with B3GLCT gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with B3GLCT gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with B3GLCT gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with B3GLCT gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
GO Biological Process Annotations 2023 biological processes involving B3GLCT gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving B3GLCT gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2023 cellular components containing B3GLCT protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing B3GLCT protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by B3GLCT gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by B3GLCT gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx eQTL 2025 SNPs regulating expression of B3GLCT gene from the GTEx eQTL 2025 dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of B3GLCT gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with B3GLCT gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of B3GLCT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of B3GLCT gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by B3GLCT gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of B3GLCT gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of B3GLCT gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PFOCR Pathway Figure Associations 2023 pathways involving B3GLCT protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving B3GLCT protein from the Wikipathways PFOCR 2024 dataset.
Reactome Pathways 2024 pathways involving B3GLCT protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of B3GLCT gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of B3GLCT gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of B3GLCT gene from the RummaGEO Gene Perturbation Signatures dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of B3GLCT protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of B3GLCT protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with B3GLCT protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.